EPIX

ESSA Pharma Inc.

7.70 USD
-0.18 (-2.28%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

ESSA Pharma Inc. stock is down -1.16% since 30 days ago. The next earnings date is May 7, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 32% of the previous 27 February’s closed higher than January. In the last 2 Unusual Options Trades, there were 2 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
09 Jan 18:59 19 Apr, 2024 5.00 CALL 99 66
15 Feb 18:47 16 Feb, 2024 5.00 CALL 60 62

About ESSA Pharma Inc.

ESSA Pharma Inc. focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study. The company has collaboration agreements with Caris Life Sciences, Inc. and Bayer Consumer Care AG.